| 1 |
34686461 | COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): A Descriptive Cytokine Pilot Sub-Study. | 2022 Jun |
1 |
| 2 |
35113170 | Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation. | 2022 Mar |
1 |
| 3 |
35178861 | Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis. | 2022 Apr |
1 |
| 4 |
32966192 | Efficacy of anti-interleukin-1 treatment in colchicine-resistant arthritis in patients with familial Mediterranean fever. | 2021 Jan |
4 |
| 5 |
33295622 | Anakinra treatment in patients with familial Mediterranean fever: a single-centre experience. | 2021 May 14 |
1 |
| 6 |
33593369 | The potential role of Colchicine in preventing coronary vascular disease in childhood-onset lupus: a new view on an old drug. | 2021 Feb 16 |
1 |
| 7 |
33813772 | The efficacy of interleukin-1 antagonist drugs in combination with colchicine in patients with FMF-AA with colchicine resistance after kidney transplantation: A study with histopathologic evidence. | 2021 Jun |
2 |
| 8 |
33913256 | Pyrin Inflammasome Activation Abrogates Interleukin-1 Receptor Antagonist, Suggesting a New Mechanism Underlying Familial Mediterranean Fever Pathogenesis. | 2021 Nov |
1 |
| 9 |
33930279 | S-allylcysteine inhibits chondrocyte inflammation to reduce human osteoarthritis via targeting RAGE, TLR4, JNK, and Nrf2 signaling: comparison with colchicine. | 2021 Oct |
1 |
| 10 |
34568239 | Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases. | 2021 |
1 |
| 11 |
34858402 | Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review. | 2021 |
1 |
| 12 |
35127599 | Real-Life Data From the Largest Pediatric Familial Mediterranean Fever Cohort. | 2021 |
1 |
| 13 |
32306038 | Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry. | 2020 Nov 1 |
2 |
| 14 |
32398478 | Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis. | 2020 Jul |
1 |
| 15 |
32477360 | Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review. | 2020 |
1 |
| 16 |
32533192 | A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever. | 2020 Oct 1 |
1 |
| 17 |
32558310 | Effect of anti-interleukin-1 treatment on quality of life in children with colchicine-resistant familial Mediterranean fever: A single-center experience. | 2020 Jul |
6 |
| 18 |
32598947 | The development of a targeted and more potent, anti-Inflammatory derivative of colchicine: Implications for gout. | 2020 Oct |
1 |
| 19 |
32645635 | The efficacy of anti- IL-1 treatment in three patients with coexisting familial Mediterranean fever and multiple sclerosis. | 2020 Oct |
1 |
| 20 |
32806879 | Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review | 2020 Nov 3 |
1 |
| 21 |
32808940 | The therapeutic potential of colchicine in the complications of COVID19. Could the immunometabolic properties of an old and cheap drug help? | 2020 Sep |
1 |
| 22 |
33551814 | Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review. | 2020 |
1 |
| 23 |
29578360 | Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis. | 2019 Mar |
1 |
| 24 |
31185840 | [Light and Shadow of Hyperuricemia - Neuroprotection, Comorbidities and Therapeutic Strategies]. | 2019 Jun |
1 |
| 25 |
31365342 | Treatment of familial mediterranean fever with canakinumab in patients who are unresponsive to colchicine. | 2019 Apr |
1 |
| 26 |
31383341 | IL-1 blockers together with colchicine may be administered as first line therapy in familial Mediterranean fever with amyloidosis. | 2019 Sep |
3 |
| 27 |
28992387 | Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients. | 2018 Jul |
2 |
| 28 |
29981275 | Canakinumab treatment in kidney transplant recipients with AA amyloidosis due to familial Mediterranean fever. | 2018 Aug |
1 |
| 29 |
30501849 | IL1-blocking therapy in colchicine-resistant familial Mediterranean fever. | 2018 Dec |
1 |
| 30 |
27328763 | Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever. | 2017 Mar |
2 |
| 31 |
28302131 | A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever. | 2017 Mar 16 |
1 |
| 32 |
28497352 | Monogenic Periodic Fever Syndromes: Treatment Options for the Pediatric Patient. | 2017 Aug |
1 |
| 33 |
25213327 | Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis. | 2016 Feb |
1 |
| 34 |
27110096 | Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature. | 2016 |
1 |
| 35 |
25139580 | Efficacy of interleukin-1 targeting treatments in patients with familial mediterranean Fever. | 2015 Feb |
3 |
| 36 |
25528863 | Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients. | 2015 Jul |
1 |
| 37 |
26001859 | Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents. | 2015 Oct |
1 |
| 38 |
26165106 | [Gout: what's new?]. | 2015 May |
1 |
| 39 |
24667287 | Treatment of hereditary autoinflammatory diseases. | 2014 May |
2 |
| 40 |
23697917 | Inflammasome and cytokine blocking strategies in autoinflammatory disorders. | 2013 Jun |
1 |
| 41 |
23742958 | Evidence-based recommendations for the practical management of Familial Mediterranean Fever. | 2013 Dec |
1 |
| 42 |
22884553 | Biologic drugs in autoinflammatory syndromes. | 2012 Nov |
1 |
| 43 |
21159830 | Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine. | 2011 Mar |
1 |
| 44 |
21277619 | Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. | 2011 Oct |
4 |
| 45 |
11154858 | Colchicine and griseofulvin inhibit VCAM-1 expression on human vascular endothelial cells - evidence for the association of VCAM-1 expression with microtubules. | 2001 Jan |
1 |
| 46 |
9452460 | Microtubule integrity regulates src-like and extracellular signal-regulated kinase activities in human pro-monocytic cells. Importance for interleukin-1 production. | 1998 Feb 6 |
3 |
| 47 |
8099911 | Disruption of microtubule network in human monocytes induces expression of interleukin-1 but not that of interleukin-6 nor tumor necrosis factor-alpha. Involvement of protein kinase A stimulation. | 1993 Jun 25 |
5 |
| 48 |
1793049 | Crystal-neutrophil interactions lead to interleukin-1 synthesis. | 1991 Sep |
2 |
| 49 |
1981242 | The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes. | 1990 Sep |
1 |
| 50 |
2242502 | Stimulation of human interleukin 1 production and specific mRNA expression by microtubule-disrupting drugs. | 1990 Dec |
2 |